ACRIN (#6677) is a global multicenter phase II trial using advanced imaging to track the effectiveness of biological treatments for brain tumors.
IB Neuro uses DSC algorithms to provide information about blood volume and blood flow in the brain. The perfusion parameters are helpful in the detection of new tumor growth or tumor recurrence and are designed to assist in creating personalized treatment plans for patients.
FDA clears MR perfusion package, June 6, 2008
Copyright © 2008 AuntMinnie.com